Zoledronate facilitates large-scale ex vivo expansion of functional γδ T cells from cancer patients for use in adoptive immunotherapy

By Kondo M.   Sakuta K.   Noguchi A.   Ariyoshi N.   Sato K.   Sato S.   Sato K.   Hosoi A.   Nakajima J.   Yoshida Y.   Shiraishi K.   Nakagawa K.   Kakimi K.  

Cytotherapy, Vol. 10, Iss. 8, 2008-01 ,pp. : 842-856

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma

By Wu Jy   Ernstoff Ms   Hill Jm   Cole B   Meehan Kr  

Cytotherapy, Vol. 8, Iss. 2, 2006-05 ,pp. : 141-148

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor

By Sutlu Tolga   Stellan Birgitta   Gilljam Mari   Quezada Hernan Concha   Nahi Hareth   Gahrton Gösta   Alici Evren  

Cytotherapy, Vol. 12, Iss. 8, 2010-12 ,pp. : 1044-1055

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15

By Wagner H-j   Sili U   Gahn B   Vigouroux S   Huls Mh   Xie W   Vignali D   Brenner Mk   Heslop He   Rooney Cm  

Cytotherapy, Vol. 5, Iss. 3, 2003-01 ,pp. : 231-240

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials

By Digiusto Dl   Cooper Ljn  

Cytotherapy, Vol. 9, Iss. 7, 2007-01 ,pp. : 613-629

Ashgate Publishing Ltd

Access to resources Recommend Favorite